{
"info": {
"nct_id": "NCT00238420",
"official_title": "A Phase I/II Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates With Muscle-Invasive Bladder Cancer",
"inclusion_criteria": "* Histologically or cytologically confirmed primary transitional cell carcinoma (TCC) of the bladder\n\n * Histologic evidence of muscularis propria invasion\n* Meets 1 of the following stage criteria:\n\n * Stage T2-4a; NX, N0, or N1; and M0 disease\n * Clinical stage T1, grade 3/3 disease AND requires definitive local therapy\n* Tumor involvement of the prostatic urethra allowed provided the following criteria are met:\n\n * Tumor was visibly completely resected\n * No evidence of stromal invasion of the prostate\n * No evidence of distant metastases by chest x-ray (or chest CT scan) within 8 weeks prior to registration\n * No evidence of distant metastases by abdominal/pelvic CT scan (or MRI scan) within 8 weeks prior to registration\n* Has undergone transurethral bladder resection (as thorough as is judged safely possible) within the past 3-8 weeks, including bimanual examination with tumor mapping\n* Sufficient tumor tissue available for HER2/neu analysis\n* Not a candidate for radical cystectomy\n* Performance status - Zubrod 0-2\n* Absolute neutrophil count >= 1,800/mm^3\n* Platelet count >= 100,000/mm^3\n* Hemoglobin >= 8.0 g/dL (transfusion or other intervention allowed)\n* Bilirubin < 2.0 mg/dL\n* Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) < 2.5 times upper limit of normal\n* No hepatic insufficiency resulting in clinical jaundice and/or coagulation defects\n* Creatinine =< 3.0 mg/dL\n* Left ventricular ejection fraction (LVEF) >= 40% by multigated acquisition scan (MUGA) scan or echocardiogram\n* No unstable angina and/or congestive heart failure requiring hospitalization within the past 6 months\n* No transmural myocardial infarction within the past 6 months\n* Not pregnant or nursing\n* No nursing for 6 months after completion of study treatment (for patients receiving trastuzumab [Herceptin®])\n* Negative pregnancy test\n* Fertile patients must use effective contraception during and for 6 months after completion of study treatment\n* Able to tolerate systemic chemotherapy and pelvic radiotherapy\n* No other invasive malignancy within the past 3 years except nonmelanoma skin cancer\n* No history of allergic reaction to study drugs\n* No history of inflammatory bowel disease\n* No acute bacterial or fungal infection requiring IV antibiotics\n* No AIDS\n* No other severe active comorbidity\n* No prior systemic chemotherapy with anthracyclines or taxanes\n* No prior systemic chemotherapy for TCC\n* No prior pelvic radiotherapy\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Histologically or cytologically confirmed primary transitional cell carcinoma (TCC) of the bladder",
"criterions": [
{
"exact_snippets": "Histologically or cytologically confirmed primary transitional cell carcinoma (TCC) of the bladder",
"criterion": "transitional cell carcinoma (TCC) of the bladder",
"requirements": [
{
"requirement_type": "confirmation method",
"expected_value": [
"histologically",
"cytologically"
]
},
{
"requirement_type": "primary",
"expected_value": true
}
]
}
]
},
{
"line": "* Histologic evidence of muscularis propria invasion",
"criterions": [
{
"exact_snippets": "Histologic evidence of muscularis propria invasion",
"criterion": "muscularis propria invasion",
"requirements": [
{
"requirement_type": "evidence",
"expected_value": "histologic"
}
]
}
]
},
{
"line": "* Meets 1 of the following stage criteria:",
"criterions": [
{
"exact_snippets": "Meets 1 of the following stage criteria",
"criterion": "stage",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": "1 of the following"
}
]
}
]
},
{
"line": "* Stage T2-4a; NX, N0, or N1; and M0 disease",
"criterions": [
{
"exact_snippets": "Stage T2-4a",
"criterion": "tumor stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 2,
"unit": "T"
},
{
"operator": "<=",
"value": 4,
"unit": "a"
}
]
}
}
]
},
{
"exact_snippets": "NX, N0, or N1",
"criterion": "lymph node involvement",
"requirements": [
{
"requirement_type": "status",
"expected_value": [
"NX",
"N0",
"N1"
]
}
]
},
{
"exact_snippets": "M0 disease",
"criterion": "metastasis",
"requirements": [
{
"requirement_type": "status",
"expected_value": "M0"
}
]
}
]
},
{
"line": "* Clinical stage T1, grade 3/3 disease AND requires definitive local therapy",
"criterions": [
{
"exact_snippets": "Clinical stage T1",
"criterion": "clinical stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "T1"
}
]
},
{
"exact_snippets": "grade 3/3 disease",
"criterion": "disease grade",
"requirements": [
{
"requirement_type": "grade",
"expected_value": "3/3"
}
]
},
{
"exact_snippets": "requires definitive local therapy",
"criterion": "definitive local therapy",
"requirements": [
{
"requirement_type": "necessity",
"expected_value": true
}
]
}
]
},
{
"line": "* Tumor involvement of the prostatic urethra allowed provided the following criteria are met:",
"criterions": [
{
"exact_snippets": "Tumor involvement of the prostatic urethra",
"criterion": "tumor involvement of the prostatic urethra",
"requirements": [
{
"requirement_type": "allowance",
"expected_value": true
}
]
}
]
},
{
"line": "* Tumor was visibly completely resected",
"criterions": [
{
"exact_snippets": "Tumor was visibly completely resected",
"criterion": "tumor resection",
"requirements": [
{
"requirement_type": "completeness",
"expected_value": "visibly completely"
}
]
}
]
},
{
"line": "* No evidence of stromal invasion of the prostate",
"criterions": [
{
"exact_snippets": "No evidence of stromal invasion of the prostate",
"criterion": "stromal invasion of the prostate",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No evidence of distant metastases by chest x-ray (or chest CT scan) within 8 weeks prior to registration",
"criterions": [
{
"exact_snippets": "No evidence of distant metastases",
"criterion": "distant metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "chest x-ray (or chest CT scan)",
"criterion": "imaging method",
"requirements": [
{
"requirement_type": "type",
"expected_value": [
"chest x-ray",
"chest CT scan"
]
}
]
},
{
"exact_snippets": "within 8 weeks prior to registration",
"criterion": "imaging timeframe",
"requirements": [
{
"requirement_type": "timeframe",
"expected_value": "within 8 weeks prior to registration"
}
]
}
]
},
{
"line": "* No evidence of distant metastases by abdominal/pelvic CT scan (or MRI scan) within 8 weeks prior to registration",
"criterions": [
{
"exact_snippets": "No evidence of distant metastases",
"criterion": "distant metastases",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "abdominal/pelvic CT scan (or MRI scan) within 8 weeks prior to registration",
"criterion": "imaging scan",
"requirements": [
{
"requirement_type": "type",
"expected_value": [
"abdominal/pelvic CT scan",
"MRI scan"
]
},
{
"requirement_type": "timing",
"expected_value": "within 8 weeks prior to registration"
}
]
}
]
},
{
"line": "* Has undergone transurethral bladder resection (as thorough as is judged safely possible) within the past 3-8 weeks, including bimanual examination with tumor mapping",
"criterions": [
{
"exact_snippets": "Has undergone transurethral bladder resection",
"criterion": "transurethral bladder resection",
"requirements": [
{
"requirement_type": "completion",
"expected_value": true
}
]
},
{
"exact_snippets": "within the past 3-8 weeks",
"criterion": "time since transurethral bladder resection",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 3,
"unit": "weeks"
},
{
"operator": "<=",
"value": 8,
"unit": "weeks"
}
]
}
}
]
},
{
"exact_snippets": "bimanual examination with tumor mapping",
"criterion": "bimanual examination with tumor mapping",
"requirements": [
{
"requirement_type": "completion",
"expected_value": true
}
]
}
]
},
{
"line": "* Sufficient tumor tissue available for HER2/neu analysis",
"criterions": [
{
"exact_snippets": "Sufficient tumor tissue available",
"criterion": "tumor tissue",
"requirements": [
{
"requirement_type": "availability",
"expected_value": true
},
{
"requirement_type": "quantity",
"expected_value": "sufficient"
}
]
},
{
"exact_snippets": "HER2/neu analysis",
"criterion": "HER2/neu analysis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Not a candidate for radical cystectomy",
"criterions": [
{
"exact_snippets": "Not a candidate for radical cystectomy",
"criterion": "radical cystectomy candidacy",
"requirements": [
{
"requirement_type": "candidacy",
"expected_value": false
}
]
}
]
},
{
"line": "* Performance status - Zubrod 0-2",
"criterions": [
{
"exact_snippets": "Performance status - Zubrod 0-2",
"criterion": "performance status",
"requirements": [
{
"requirement_type": "scale",
"expected_value": "Zubrod"
},
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 0,
"unit": "N/A"
},
{
"operator": "<=",
"value": 2,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "* Absolute neutrophil count >= 1,800/mm^3",
"criterions": [
{
"exact_snippets": "Absolute neutrophil count >= 1,800/mm^3",
"criterion": "absolute neutrophil count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 1800,
"unit": "mm^3"
}
}
]
}
]
},
{
"line": "* Platelet count >= 100,000/mm^3",
"criterions": [
{
"exact_snippets": "Platelet count >= 100,000/mm^3",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 100000,
"unit": "mm^3"
}
}
]
}
]
},
{
"line": "* Hemoglobin >= 8.0 g/dL (transfusion or other intervention allowed)",
"criterions": [
{
"exact_snippets": "Hemoglobin >= 8.0 g/dL",
"criterion": "hemoglobin level",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": ">=",
"value": 8.0,
"unit": "g/dL"
}
}
]
}
]
},
{
"line": "* Bilirubin < 2.0 mg/dL",
"criterions": [
{
"exact_snippets": "Bilirubin < 2.0 mg/dL",
"criterion": "bilirubin level",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 2.0,
"unit": "mg/dL"
}
}
]
}
]
},
{
"line": "* Serum glutamic oxaloacetic transaminase (SGOT) and serum glutamate pyruvate transaminase (SGPT) < 2.5 times upper limit of normal",
"criterions": [
{
"exact_snippets": "Serum glutamic oxaloacetic transaminase (SGOT) ... < 2.5 times upper limit of normal",
"criterion": "Serum glutamic oxaloacetic transaminase (SGOT)",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 2.5,
"unit": "times upper limit of normal"
}
}
]
},
{
"exact_snippets": "serum glutamate pyruvate transaminase (SGPT) < 2.5 times upper limit of normal",
"criterion": "serum glutamate pyruvate transaminase (SGPT)",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<",
"value": 2.5,
"unit": "times upper limit of normal"
}
}
]
}
]
},
{
"line": "* No hepatic insufficiency resulting in clinical jaundice and/or coagulation defects",
"criterions": [
{
"exact_snippets": "No hepatic insufficiency",
"criterion": "hepatic insufficiency",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "clinical jaundice",
"criterion": "clinical jaundice",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "coagulation defects",
"criterion": "coagulation defects",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Creatinine =< 3.0 mg/dL",
"criterions": [
{
"exact_snippets": "Creatinine =< 3.0 mg/dL",
"criterion": "creatinine level",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 3.0,
"unit": "mg/dL"
}
}
]
}
]
},
{
"line": "* Left ventricular ejection fraction (LVEF) >= 40% by multigated acquisition scan (MUGA) scan or echocardiogram",
"criterions": [
{
"exact_snippets": "Left ventricular ejection fraction (LVEF) >= 40%",
"criterion": "left ventricular ejection fraction (LVEF)",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">=",
"value": 40,
"unit": "%"
}
}
]
}
]
},
{
"line": "* No unstable angina and/or congestive heart failure requiring hospitalization within the past 6 months",
"criterions": [
{
"exact_snippets": "No unstable angina",
"criterion": "unstable angina",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No ... congestive heart failure requiring hospitalization within the past 6 months",
"criterion": "congestive heart failure",
"requirements": [
{
"requirement_type": "hospitalization",
"expected_value": {
"operator": "<",
"value": 1,
"unit": "times"
}
},
{
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
}
]
},
{
"line": "* No transmural myocardial infarction within the past 6 months",
"criterions": [
{
"exact_snippets": "No transmural myocardial infarction within the past 6 months",
"criterion": "transmural myocardial infarction",
"requirements": [
{
"requirement_type": "time since last occurrence",
"expected_value": {
"comparisons": [
{
"operator": "<",
"value": 6,
"unit": "months"
}
]
}
}
]
}
]
},
{
"line": "* No nursing for 6 months after completion of study treatment (for patients receiving trastuzumab [Herceptin®])",
"criterions": [
{
"exact_snippets": "No nursing for 6 months after completion of study treatment (for patients receiving trastuzumab [Herceptin®])",
"criterion": "nursing",
"requirements": [
{
"requirement_type": "prohibition",
"expected_value": true
},
{
"requirement_type": "duration",
"expected_value": {
"operator": "=",
"value": 6,
"unit": "months"
}
}
]
}
]
},
{
"line": "* Negative pregnancy test",
"criterions": [
{
"exact_snippets": "Negative pregnancy test",
"criterion": "pregnancy test",
"requirements": [
{
"requirement_type": "result",
"expected_value": "negative"
}
]
}
]
},
{
"line": "* Fertile patients must use effective contraception during and for 6 months after completion of study treatment",
"criterions": [
{
"exact_snippets": "Fertile patients",
"criterion": "fertility",
"requirements": [
{
"requirement_type": "status",
"expected_value": "fertile"
}
]
},
{
"exact_snippets": "must use effective contraception during and for 6 months after completion of study treatment",
"criterion": "contraception use",
"requirements": [
{
"requirement_type": "duration",
"expected_value": "during and for 6 months after completion of study treatment"
}
]
}
]
},
{
"line": "* Able to tolerate systemic chemotherapy and pelvic radiotherapy",
"criterions": [
{
"exact_snippets": "Able to tolerate systemic chemotherapy",
"criterion": "systemic chemotherapy tolerance",
"requirements": [
{
"requirement_type": "tolerance",
"expected_value": true
}
]
},
{
"exact_snippets": "Able to tolerate ... pelvic radiotherapy",
"criterion": "pelvic radiotherapy tolerance",
"requirements": [
{
"requirement_type": "tolerance",
"expected_value": true
}
]
}
]
},
{
"line": "* No other invasive malignancy within the past 3 years except nonmelanoma skin cancer",
"criterions": [
{
"exact_snippets": "No other invasive malignancy within the past 3 years",
"criterion": "invasive malignancy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
},
{
"requirement_type": "time frame",
"expected_value": {
"comparisons": [
{
"operator": "<=",
"value": 3,
"unit": "years"
}
]
}
}
]
},
{
"exact_snippets": "except nonmelanoma skin cancer",
"criterion": "nonmelanoma skin cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* No history of allergic reaction to study drugs",
"criterions": [
{
"exact_snippets": "No history of allergic reaction to study drugs",
"criterion": "allergic reaction to study drugs",
"requirements": [
{
"requirement_type": "history",
"expected_value": false
}
]
}
]
},
{
"line": "* No history of inflammatory bowel disease",
"criterions": [
{
"exact_snippets": "No history of inflammatory bowel disease",
"criterion": "inflammatory bowel disease",
"requirements": [
{
"requirement_type": "history",
"expected_value": false
}
]
}
]
},
{
"line": "* No acute bacterial or fungal infection requiring IV antibiotics",
"criterions": [
{
"exact_snippets": "No acute bacterial or fungal infection",
"criterion": "acute bacterial or fungal infection",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "requiring IV antibiotics",
"criterion": "IV antibiotics",
"requirements": [
{
"requirement_type": "necessity",
"expected_value": false
}
]
}
]
},
{
"line": "* No AIDS",
"criterions": [
{
"exact_snippets": "No AIDS",
"criterion": "AIDS",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No other severe active comorbidity",
"criterions": [
{
"exact_snippets": "No other severe active comorbidity",
"criterion": "severe active comorbidity",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No prior systemic chemotherapy with anthracyclines or taxanes",
"criterions": [
{
"exact_snippets": "No prior systemic chemotherapy with anthracyclines",
"criterion": "prior systemic chemotherapy with anthracyclines",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No prior systemic chemotherapy with ... taxanes",
"criterion": "prior systemic chemotherapy with taxanes",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No prior systemic chemotherapy for TCC",
"criterions": [
{
"exact_snippets": "No prior systemic chemotherapy for TCC",
"criterion": "prior systemic chemotherapy for TCC",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No prior pelvic radiotherapy",
"criterions": [
{
"exact_snippets": "No prior pelvic radiotherapy",
"criterion": "pelvic radiotherapy",
"requirements": [
{
"requirement_type": "prior treatment",
"expected_value": false
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [],
"miscellaneous_lines": [],
"failed_inclusion": [
{
"line": "* Not pregnant or nursing",
"criterions": [
{
"exact_snippets": "Not pregnant",
"criterion": "pregnancy",
"requirements": [
{
"requirement_type": "status",
"expected_value": false
}
]
},
{
"exact_snippets": "not ... nursing",
"criterion": "nursing",
"requirements": [
{
"requirement_type": "status",
"expected_value": false
}
]
}
]
}
],
"failed_exclusion": [],
"failed_miscellaneous": []
}